In line with our commitment to keep the public informed of developments relating to the vaccine rollout strategy, we wish to communicate recent developments of national importance.

When we held the press briefing on Sunday, 3 January 2021, we indicated that, in so far as our negotiations with individual manufacturing companies was concerned, we were bound by the non disclosure agreements and confidentiality clauses that we had agreed to. We accept these as we recognise that we are negotiation with independent private companies who may not want details disclosed until certain or all terms and conditions between the parties are met.

 

Full Statement Attached

 

Issued by The Department of Health